Thought Leader:

Michelle Hoiseth, Vice President, PAREXEL Access

May 31, 2017

In this episode, Michelle Hoiseth discusses Real-World Evidence and clinical research — how companies can generate it, their approach to it, the benefits of it, and how PAREXEL helps companies design and implement their Real-World Evidence strategy. Listen now using the podc … Read More »

Thought Leader:

Michael Carlin, VP, HCP Engagement, TrialCard

May 22, 2017

In this episode, Michael Carlin talks about how Virtual Engagements are addressing the issue of limited physician access by pharmaceutical reps, including keys to success, measuring results, and the degree of success with these programs. There is also a related white paper e … Read More »

Thought Leader:

Peter Steiger, Ph.D. Vice President and Chief Scientific Officer, Patient Technology Solutions, PAREXEL

May 10, 2017

In this episode, Dr. Steiger talks about rescue studies, specifically when to start thinking about bringing in a new vendor, what capabilities to look for in a vendor, three case studies and more. You can also download a related case study entitled “Implementing a Study Desi … Read More »

Thought Leaders:

Terek Peterson, Senior Director of Global Statistical Standards, Chiltern
Dave Izard, Senior Director of Clinical Data Standards, Chiltern

March 6, 2017

In this episode, we hear from two experts on the FDA’s regulations regarding electronic submissions. They cover issues such as what has changed over the last 3 years, the latest FDA guidance documents, reasons for complying, and deploying standards when clinical development … Read More »

Thought Leader:

Heather Gartman, Managing Director, Public Relations Group, inVentiv Health

January 26, 2017

Heather Gartman discusses patient advocacy in the mental health space, including problem with underfunded research, the numerous stakeholders involved, and ways pharma and these stakeholders can come together to better support this extremely important area of the healthcare … Read More »

Thought Leader:

Peter Belden, President of ICS, an AmerisourceBergen company

November 9, 2016

In this episode, Pete Belden talks about the role of third-party logistics in the commercialization process, how manufactures should solve challenges using 3PL partners, and where 3PL services are headed in the future.

Thought Leader:

Dr. Kate Perry, Director of Behavioral Science, Atlantis Healthcare

October 19, 2016

Dr. Perry discusses the complexities of self-management across chronic disease. We explore the application of health psychology and the role of technology in helping pharma support patients to stay on track with their prescribed treatment.

Thought Leaders:

Prithul Bom, MBA, RAC, ASQ-CSQE, Senior Director, Scientific Affairs, TA Leader for Medical Device & Diagnostics, Chiltern
Lisa Moore, PhD, RN, Senior Director, Scientific Affairs, TA Leader for Cardiovascular, Chiltern

October 3, 2016

In this episode, we talk about how smartphones intersect with medical devices, what makes an app a mobile medical app, why companies should include a mobile medical app with their Class II or Class III medical devices, why Human Factors and Usability Engineering are so impor … Read More »

Thought Leaders:

Chiquita Brooks-LaSure, Managing Director, Manatt Health
Joel S. Ario, Managing Director, Manatt Health

September 13, 2016

The 2016 election will have a major impact on both federal and state healthcare policy. To be sure your organization is prepared for all the possibilities, it’s critical to understand the political dynamics that will be at play under each potential scenario—and what they wil … Read More »

Thought Leaders:

Angie Wheeler, CEO, Cello Health Insight, Chicago
Jim McDermott, Vice President, Cello Health BioConsulting
John Howley, Managing Director, Cello Health Communications, US

August 15, 2016

In this episode, our panel of experts will talk about the state of the rare disease space, and how to succeed in this growing arena. There is also a related white paper on this topic, which you can download using the link at the bottom of this listing.

Thought Leader:

Chuck Reed, Group Vice President, Pharmacy Innovation & Solutions, AmerisourceBergen Drug Corporation

August 12, 2016

In this episode, Chuck Reed talks about the Elevate Provider Network, how it helps provide better patient care, and how it benefits other stakeholders in the prescription medicine ecosystem.

Thought Leader:

Michael Carlin, Vice President, TrialCard

July 28, 2016

In this episode, Michael Carlin of TrialCard discusses rare diseases and orphan drugs, and how life sciences companies can overcome the many business challenges associated with these types of disease states. There is also a related white paper entitled “No Patient Left Behin … Read More »

FEEDBACK